New drug Nerlynx approved by the FDA as new treatment to reduce risk of breast cancer recurrence
With increasing incidences of cancer and its recurrence, the scientific community is always trying to invent new remedies and...
Oncology
Ribociclib approved as the first-line agent for metastatic breast cancer
Breast cancer is the second leading cause of cancer-related mortality in women, after lung cancer.1 The American Cancer Society...
Lynparza as maintenance therapy for BRCA-mutated ovarian cancer patients
Ovarian cancer is the 7th most commonly diagnosed cancer in women worldwide1 and the 5th most common cause of...